Literature DB >> 11684021

Generation of stable mRNA fragments and translation of N-truncated proteins induced by antisense oligodeoxynucleotides.

C Thoma1, P Hasselblatt, J Köck, S F Chang, B Hockenjos, H Will, M W Hentze, H E Blum, F von Weizsäcker, W B Offensperger.   

Abstract

Binding of phosphorothioate-modified antisense oligodeoxynucleotides (AS ODNs) to target mRNAs is commonly thought to mediate RNA degradation or block of translation. Here we demonstrate cleavage of target mRNAs within the AS ODN binding region with subsequent degradation of the 5' but not the 3' cleavage product. Some, if not all, 3' mRNA fragments lacked a 5' cap structure, whereas their poly(A) tail length remained unchanged. Furthermore, they were efficiently translated into N-terminally truncated proteins as demonstrated in three settings: production of shortened hepadnaviral surface proteins, alteration of the subcellular localization of a fluorescent protein, and shift of the transcription factor C/EBPalpha isoform expression levels. Thus, AS treatment may result in the synthesis of N-truncated proteins with biologically relevant effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684021     DOI: 10.1016/s1097-2765(01)00364-1

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  14 in total

1.  Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning.

Authors:  Déborah Prévôt; Didier Décimo; Cécile H Herbreteau; Florence Roux; Jérôme Garin; Jean-Luc Darlix; Théophile Ohlmann
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

2.  Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome.

Authors:  Tim R Mercer; Marcel E Dinger; Cameron P Bracken; Gabriel Kolle; Jan M Szubert; Darren J Korbie; Marjan E Askarian-Amiri; Brooke B Gardiner; Gregory J Goodall; Sean M Grimmond; John S Mattick
Journal:  Genome Res       Date:  2010-11-02       Impact factor: 9.043

3.  Identification of a cytoplasmic complex that adds a cap onto 5'-monophosphate RNA.

Authors:  Yuichi Otsuka; Nancy L Kedersha; Daniel R Schoenberg
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

4.  A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.

Authors:  Edwin H Yau; Mark C Butler; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2016-05-25       Impact factor: 3.467

5.  Mos is not required for the initiation of meiotic maturation in Xenopus oocytes.

Authors:  Aude Dupré; Catherine Jessus; René Ozon; Olivier Haccard
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

6.  Identification of cytoplasmic capping targets reveals a role for cap homeostasis in translation and mRNA stability.

Authors:  Chandrama Mukherjee; Deepak P Patil; Brian A Kennedy; Baskar Bakthavachalu; Ralf Bundschuh; Daniel R Schoenberg
Journal:  Cell Rep       Date:  2012-08-23       Impact factor: 9.423

Review 7.  A recap of RNA recapping.

Authors:  Jackson B Trotman; Daniel R Schoenberg
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-09-05       Impact factor: 9.957

8.  The hDcp2 protein is a mammalian mRNA decapping enzyme.

Authors:  Zuoren Wang; Xinfu Jiao; Anne Carr-Schmid; Megerditch Kiledjian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

9.  The scavenger mRNA decapping enzyme DcpS is a member of the HIT family of pyrophosphatases.

Authors:  Hudan Liu; Nancy D Rodgers; Xinfu Jiao; Megerditch Kiledjian
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

Review 10.  Re-capping the message.

Authors:  Daniel R Schoenberg; Lynne E Maquat
Journal:  Trends Biochem Sci       Date:  2009-09-02       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.